Pollution and respiratory disease: can diet or supplements help? A review

por Whyand, T., Hurst, J. R., Beckles, M., Caplin, M. E.
Publicado 2018

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms

por Khan, M S, Luong, T V, Watkins, J, Toumpanakis, C, Caplin, M E, Meyer, T
Publicado 2013

1110P COVID-19 pandemic impact on healthcare professionals treating patients with neuroendocrine tumors (NET): An international NET CONNECT survey

por Hernando, J., Lamarca, A., Cives, M., Caplin, M.E., Pavel, M.E.
Publicado 2021

α-Fetoprotein and human chorionic gonadotrophin-β as prognostic markers in neuroendocrine tumour patients

por Shah, T, Srirajaskanthan, R, Bhogal, M, Toubanakis, C, Meyer, T, Noonan, A, Witney-Smith, C, Amin, T, Bhogal, P, Sivathasan, N, Warner, B, Hochhauser, D, Caplin, M E
Publicado 2008

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours

por Turner, N C, Strauss, S J, Sarker, D, Gillmore, R, Kirkwood, A, Hackshaw, A, Papadopoulou, A, Bell, J, Kayani, I, Toumpanakis, C, Grillo, F, Mayer, A, Hochhauser, D, Begent, R H, Caplin, M E, Meyer, T
Publicado 2010

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

por Ramage, John K, Ahmed, A, Ardill, J, Bax, N, Breen, D J, Caplin, M E, Corrie, P, Davar, J, Davies, A H, Lewington, V, Meyer, T, Newell-Price, J, Poston, G, Reed, N, Rockall, A, Steward, W, Thakker, R V, Toubanakis, C, Valle, J, Verbeke, C, Grossman, A B
Publicado 2011